Search Result "antifibrotic"
Antifibrotic Drugs for COVID-19: From Orphan Drugs to Blockbusters?
Journal: Current Respiratory Medicine Reviews
Volume: 17 Issue: 1 Year: 2021 Page: 8-12
Author(s): Leander Corrie,MD Muzaffar-Ur-Rehman,Latha Kukatil,Devasari Manasa,Adepu Shirisha
Synthesis and In vivo Antifibrotic Activity of Novel Leflunomide Analogues
Journal: Letters in Drug Design & Discovery
Volume: 13 Issue: 9 Year: 2016 Page: 912-920
Author(s): Abdelrahman Hamdi, Eman Said, Abdelbasset A. Farahat, Serry A. A. El-Bialy, Mohammed A. M. Massoud
Repurposing Anticancer Drugs for the Treatment of Idiopathic Pulmonary Fibrosis and Antifibrotic Drugs for the Treatment of Cancer: State of the Art
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 11 Year: 2021 Page: 2234-2247
Author(s): Panagiotis Paliogiannis,Sara Solveig Fois,Alessandro Giuseppe Fois,Antonio Cossu,Giuseppe Palmieri,Gianfranco Pintus
Progress Towards Discovery of Antifibrotic Drugs Targeting Synthesis of Type I Collagen
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 3410-3416
Author(s): D. Fritz, L. Cai, L. Stefanovic, B. Stefanovic
Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derivedMesenchymal Stem Cells in a CCl4-induced Mouse Model of LiverFibrosis
Journal: Current Stem Cell Research & Therapy
Volume: 19 Issue: 11 Year: 2024 Page: 1484-1496
Author(s):
Real-World Comprehensive Disease Management of Patients With Idiopathic Pulmonary Fibrosis
Journal: Current Respiratory Medicine Reviews
Volume: 15 Issue: 1 Year: 2019 Page: 4-15
Author(s): Wendi Mason,Sally McLaughlin,Sophy Dedopoulos,Erin Mahoney,Tonja Meadows,John L. Stauffer,Lisa H. Lancaster
Current Progress in Antifibroitcs
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 3082-3092
Author(s): S. A.A. El Bialy, K. F. Abd El Kader, M. B. El-Ashmawy
Adrenomedullin in Heart Failure: Molecular Mechanism and Therapeutic Implication
Journal: Current Hypertension Reviews
Volume: 7 Issue: 4 Year: 2011 Page: 273-283
Author(s): Toshio Nishikimi, Kazuwa Nakao, Kenji Kangawa
Current and Future Treatment Options in Idiopathic Pulmonary Fibrosis
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 9 Issue: 3 Year: 2010 Page: 158-172
Author(s): Hans-Peter Hauber, Markus Blaukovitsch
Daclatasvir and Sofosbuvir Mitigate Hepatic Fibrosis Through Downregulation of TNF-α / NF-κB Signaling Pathway
Journal: Current Molecular Pharmacology
Volume: 13 Issue: 4 Year: 2020 Page: 318-327
Author(s): Sherin Zakaria,Alaa E. El-Sisi